Updated:
Brain Trust Accelerator Fund
Brain Trust Accelerator Fund is a private equity firm headquartered in Burlingame, United States. The fund manages $33 million in assets under management.
Brain Trust Accelerator Fund
Brain Trust Accelerator Fund is a private equity firm headquartered in Burlingame, United States. The fund manages $33 million in assets under management. It specializes in investing in early‑stage companies that develop treatments for brain‑related diseases. To date the fund has completed 16 investments across this therapeutic focus. Among its recent activities, the fund participated in a Series B financing of NeuroTherapia on August 06 2024. The firm has also guided three portfolio companies to exit, including the December 23 2024 exit of Thirteen Lune. Further information about the fund’s strategy and portfolio can be found on its website, braintrustvc.com.
General information
Firm type
Private Equity
AUM
$33 million
Location
Region
North America
Country
United States
City
Burlingame
Corporate office
Burlingame, United States
Sector focus
Frequently asked questions
What type of companies does Brain Trust Accelerator Fund invest in?
The fund invests in early‑stage companies addressing brain‑related diseases.
How many investments has the fund made?
The fund has made 16 investments.
Which company received a Series B investment from the fund in August 2024?
NeuroTherapia received a Series B investment on August 06 2024.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: